Related Experiment Videos
Physiologically Based Pharmacokinetic and Absorption Modeling for Osmotic Pump Products
Zhanglin Ni1, Arjang Talattof1, Jianghong Fan1
1Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, US Food and Drug Administration, Silver Spring, Maryland, USA.
The AAPS Journal
|March 31, 2017
Summary
Physiologically based pharmacokinetic modeling accurately predicts oral extended-release drug performance from osmotic pumps. In vitro dissolution generally predicts in vivo profiles, highlighting the reliability of this drug delivery system.
Area of Science:
- Pharmacokinetics
- Drug Delivery Systems
- Computational Modeling
Background:
- Oral extended-release (ER) drug products utilizing osmotic pump systems offer predictable drug release.
- Understanding the in vivo relevance of in vitro dissolution is crucial for formulation development and regulatory assessment.
Purpose of the Study:
- To systematically evaluate the in vivo predictability of in vitro dissolution for oral ER drug products based on osmotic pumps.
- To assess the influence of physiological factors on drug absorption and pharmacokinetic profiles.
Main Methods:
- Physiologically based pharmacokinetic (PBPK) and absorption modeling approaches were utilized.
- The study encompassed Biopharmaceutics Classification System (BCS) classes 1, 2, and 3 drug products with varying half-lives.
- Colonic absorption models were adjusted to account for regional gastrointestinal transit and permeability.
Main Results:
- In vitro dissolution was generally predictive of in vivo pharmacokinetic (PK) profiles for osmotic pump systems.
- Osmotic pump drug release demonstrated reduced susceptibility to gastrointestinal environmental factors (pH, food, hydrodynamics).
- Maximum plasma concentration (Cmax) and area under the concentration-time curve (AUCt) were sensitive to colon permeability and GI transit times in a drug product-specific manner.
Conclusions:
- PBPK modeling is advantageous for addressing product-specific questions in drug development and regulatory reviews.
- While further methodological refinement for colonic absorption and GI transit is needed, the current approach demonstrates significant utility.
- The inherent stability of osmotic pump release in the GI tract enhances the predictability of in vitro dissolution data.